|
Volumn 268, Issue 9, 2011, Pages 1247-1248
|
The evolving management of laryngeal neuroendocrine carcinomas
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
LOMUSTINE;
METHOTREXATE;
VINCRISTINE;
CANCER CLASSIFICATION;
CANCER COMBINATION CHEMOTHERAPY;
CANCER DIAGNOSIS;
CANCER RADIOTHERAPY;
CARBON DIOXIDE LASER;
CARCINOID;
CERVICAL LYMPH NODE;
EDITORIAL;
ELECTIVE NECK DISSECTION;
HUMAN;
IMMUNOHISTOCHEMISTRY;
LARYNGECTOMY;
LARYNX ATYPICAL CARCINOID;
LARYNX CARCINOMA;
LARYNX EPITHELIUM NEUROENDOCRINE CARCINOMA;
LARYNX LARGE CELL NEUROENDOCRINE CARCINOMA;
LARYNX NEUROENDOCRINE CARCINOMA;
LARYNX SMALL CELL NEUROENDOCRINE CARCINOMA;
LASER SURGERY;
LYMPH NODE METASTASIS;
NECK DISSECTION;
NEUROENDOCRINE TUMOR;
PRIORITY JOURNAL;
SELECTIVE NECK DISSECTION;
SKIN METASTASIS;
SUPRAGLOTTIC LARYNGECTOMY;
TREATMENT INDICATION;
TUMOR DIFFERENTIATION;
CARCINOMA, NEUROENDOCRINE;
FEMALE;
HUMANS;
LARYNGEAL NEOPLASMS;
LARYNGECTOMY;
LASER THERAPY;
MALE;
NEOPLASM INVASIVENESS;
NEOPLASM STAGING;
PROGNOSIS;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
EID: 80052758365
PISSN: 09374477
EISSN: 14344726
Source Type: Journal
DOI: 10.1007/s00405-011-1666-z Document Type: Editorial |
Times cited : (19)
|
References (12)
|